Inflammatory biomarker in adipose stem cells of women with endometrial cancer.
暂无分享,去创建一个
J. Rubin | K. Marra | A. Lokshin | J. Kelley | A. Vlad | R. Edwards | F. Linkov | S. Goughnour | P. Sukumvanich | J. Comerci | L. Kokai | S. Adambekov | B. Philips | R. Edwards
[1] R. Ramanathan,et al. Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. , 2017, Gynecologic oncology.
[2] R. Ramanathan,et al. Endometrial cancer associated biomarkers in bariatric surgery candidates: exploration of racial differences. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[3] Jianhong Zhou,et al. YT521 promotes metastases of endometrial cancer by differential splicing of vascular endothelial growth factor A , 2016, Tumor Biology.
[4] J. Rubin,et al. Adipose Stem Cell Function Maintained with Age: An Intra-Subject Study of Long-Term Cryopreserved Cells , 2016, Aesthetic surgery journal.
[5] R. Simó,et al. Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue , 2016, Stem cells translational medicine.
[6] Sean M. Kearney,et al. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. , 2015, Cancer research.
[7] A. Klopp,et al. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. , 2015, Cancer research.
[8] A. Althouse,et al. USA endometrial cancer projections to 2030: should we be concerned? , 2014, Future oncology.
[9] C. Hung,et al. Measurement of Visceral Fat: Should We Include Retroperitoneal Fat? , 2014, PloS one.
[10] A. Tavartkiladze,et al. [Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma]. , 2014, Georgian medical news.
[11] Robert A. Edwards,et al. Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[12] J. Rubin,et al. The role of adipose-derived stem cells in endometrial cancer proliferation , 2014, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[13] J. Rubin,et al. Adipose-derived stem cells: Implications in tissue regeneration. , 2014, World journal of stem cells.
[14] J. Rubin,et al. Adipose stem cells: biology and clinical applications for tissue repair and regeneration. , 2014, Translational research : the journal of laboratory and clinical medicine.
[15] J. Rubin,et al. Prevalence of Endogenous CD34+ Adipose Stem Cells Predicts Human Fat Graft Retention in a Xenograft Model , 2013, Plastic and reconstructive surgery.
[16] J. Gimble,et al. Discussion: Prevalence of Endogenous CD34+ Adipose Stem Cells Predicts Human Fat Graft Retention in a Xenograft Model , 2013, Plastic and reconstructive surgery.
[17] M. Sherman,et al. Recent changes in endometrial cancer trends among menopausal-age U.S. women. , 2013, Cancer epidemiology.
[18] C. Friedenreich,et al. Case–control study of inflammatory markers and the risk of endometrial cancer , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[19] E. Crosbie,et al. Obesity‐driven endometrial cancer: is weight loss the answer? , 2013, BJOG : an international journal of obstetrics and gynaecology.
[20] J. Chang-Claude,et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. , 2013, American journal of epidemiology.
[21] E. Lam,et al. The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma. , 2012, Cytokine.
[22] C. Apovian,et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity , 2012, Nutrition & Diabetes.
[23] Sudhir R. Chowbina,et al. Not All Fat Is Equal: Differential Gene Expression and Potential Therapeutic Targets in Subcutaneous Adipose, Visceral Adipose, and Endometrium of Obese Women With and Without Endometrial Cancer , 2012, International Journal of Gynecologic Cancer.
[24] W. Woodward,et al. Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors , 2011, Clinical Cancer Research.
[25] Ngai Na Co,et al. Understanding obesity and endometrial cancer risk: opportunities for prevention. , 2011, American journal of obstetrics and gynecology.
[26] M. Moreno-Aliaga,et al. Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. , 2011, Biochimica et biophysica acta.
[27] J. DeLany,et al. Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction. , 2011, Gynecologic oncology.
[28] V. Staalesen,et al. Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents , 2011, Journal of obesity.
[29] A. Ghaderi,et al. Bcl-2 and Fas Expressions Correlate with Proliferative Specificity of Adipose-derived Stem Cells (ASCs) in Breast Cancer , 2011, Immunological investigations.
[30] A. Madan,et al. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. , 2010, Metabolism: clinical and experimental.
[31] J. Rubin,et al. Adipose tissue regeneration. , 2010, Current stem cell research & therapy.
[32] J. Fain. Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review , 2010, Mediators of inflammation.
[33] M. Ibrahim. Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[34] F. Visseren,et al. Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[35] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[36] P. Froguel,et al. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[38] A. Lokshin,et al. Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up? , 2007, Future oncology.
[39] R. Yu,et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters , 2006, International Journal of Obesity.
[40] Sanjin Zvonic,et al. Immunophenotype of Human Adipose‐Derived Cells: Temporal Changes in Stromal‐Associated and Stem Cell–Associated Markers , 2006, Stem cells.
[41] William L. Bigbee,et al. Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[42] T. Tamaya,et al. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[43] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[44] M. Oehler,et al. Endometrial cancer , 2005, Cell and Tissue Research.
[45] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.